Open AccessThe Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances the Antitumoral Activity of Gemcitabine in Human Pancreatic Cancer Cell Lines
Author(s) -
Luise Maute Johannes Wicht
Publication year - 2014
Publication title -
journal of integrative oncology
Language(s) - English
Resource type - Journals
ISSN - 2329-6771
DOI - 10.4172/2329-6771.1000133
Subject(s) - gemcitabine , discovery and development of mtor inhibitors , medicine , pi3k/akt/mtor pathway , pancreatic cancer , cancer , cancer cell lines , cancer research , dual (grammatical number) , oncology , bioinformatics , pharmacology , cancer cell , apoptosis , biology , genetics , art , literature